What are the trimester‑specific reference intervals for thyroid‑stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3), and total thyroxine (tT4) during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trimester-Specific Reference Intervals for Thyroid Function Tests in Pregnancy

First Trimester Reference Intervals

TSH reference intervals in the first trimester range from 0.04-0.34 mIU/L (lower limit) to 2.53-3.81 mIU/L (upper limit) across different populations and assay platforms. 1, 2, 3, 4

  • TSH: The most robust US data using Roche analyzers shows a first trimester range of 0.16-2.82 mIU/L 1
  • Free T4 (FT4): 12.0-18.5 pmol/L (or 0.8-1.53 ng/dL when converted) 1, 4
  • Total T4 (tT4): 62.8-177.9 nmol/L (or 7.31-15.00 μg/dL) 1, 4
  • Free T3 (FT3): 1.5-3.4 nmol/L (or 0.90-2.51 ng/mL) 1, 4

Second Trimester Reference Intervals

TSH increases slightly in the second trimester, with upper limits ranging from 2.73-4.07 mIU/L, while free T4 progressively decreases throughout pregnancy. 1, 2, 3

  • TSH: 0.18-0.68 mIU/L (lower) to 2.73-4.07 mIU/L (upper) across populations 1, 2, 3
  • Free T4 (FT4): 10.2-16.6 pmol/L (or 0.7-1.20 ng/dL), representing a decline from first trimester 1, 4
  • Total T4 (tT4): 66.6-176.0 nmol/L (or 8.92-17.38 μg/dL) 1, 4
  • Free T3 (FT3): 1.56-3.6 nmol/L (or 1.99-2.87 ng/mL) 1, 4

Third Trimester Reference Intervals

By the third trimester, free T4 decreases by approximately 14.8% and free T3 by 13.2% compared to first trimester values, while TSH stabilizes at slightly higher levels than early pregnancy. 3

  • TSH: 0.60-0.63 mIU/L (lower) to 4.00-4.50 mIU/L (upper) 3, 4
  • Free T4 (FT4): Median values are 14.8% lower than first trimester, with ranges of 0.7-1.20 ng/dL 3, 4
  • Total T4 (tT4): 7.98-17.70 μg/dL 4
  • Free T3 (FT3): Median values are 13.2% lower than first trimester, with ranges of 1.20-2.70 ng/mL 3, 4

Critical Implementation Considerations

Institutions must calculate their own pregnancy-specific reference intervals rather than relying on universal cutoffs, as substantial variation exists between populations, assay platforms, and geographic regions. 5

  • Population-specific factors including ethnicity, body mass index, and iodine status significantly affect thyroid function reference intervals during pregnancy 5
  • The US data using Roche analyzers represents the most directly applicable reference for American laboratories using this platform 1
  • Mediterranean populations (Greece) show slightly different ranges (TSH 0.05-2.53 first trimester, 0.18-2.73 second trimester) 2
  • Iraqi populations demonstrate even wider variation (TSH 0.04-3.77 first trimester), highlighting the critical importance of population-specific ranges 4

Clinical Significance of Accurate Reference Intervals

Even small subclinical variations in thyroid function have been associated with detrimental pregnancy outcomes including low birth weight, pregnancy loss, preeclampsia, and neurodevelopmental effects in offspring. 5

  • Using incorrect reference intervals leads to misclassification of thyroid disorders and inappropriate treatment decisions 5, 2
  • Between 5.9-6.8% of pregnant women have TSH values exceeding population-specific upper limits when appropriate trimester-specific ranges are applied 2
  • Standard non-pregnant reference intervals are completely unsuitable for pregnancy and result in both under-diagnosis and over-treatment 5, 3

Assay-Specific Recommendations

For laboratories using Roche platforms (Modular e170 or cobas e801), the US-derived reference intervals provide the most appropriate starting point for American populations. 1, 3

  • Roche platform data from Caucasian populations shows consistent patterns across studies, with TSH 0.34-3.81 mIU/L in first trimester 3
  • Electrochemiluminescence techniques may yield different absolute values requiring platform-specific validation 4
  • The progressive decline in free T4 and free T3 throughout pregnancy is consistent across all assay platforms and populations 1, 3, 4

Related Questions

What are the trimester-specific reference intervals for thyroid function tests during pregnancy?
What is the normal range for Thyroid-Stimulating Hormone (TSH) levels in a pregnant woman during her 3rd trimester?
What laboratory test is best to monitor a patient with hyperthyroidism (an overactive thyroid gland) during pregnancy?
What is the normal range for Thyroid-Stimulating Hormone (TSH) levels in the second trimester of pregnancy?
What is the target range for Thyroid-Stimulating Hormone (TSH) levels during pregnancy?
Which antihypertensive agent is preferred for a patient with chronic kidney disease stage 3b (eGFR ≈ 30‑44 mL/min/1.73 m²) and uncontrolled diabetes mellitus?
What is the recommended adjunctive corticosteroid regimen (including dexamethasone dose, route, taper schedule, pediatric dosing, prednisolone alternative, and contraindications) for adults and children with suspected tuberculous meningitis?
What is the appropriate adult dose, administration schedule, contraindications, and safety monitoring for mebeverine 200 mg in a patient with irritable bowel syndrome?
What is the appropriate workup and treatment for a newborn who develops jaundice within the first 24 hours with a rapid rise in bilirubin and evidence of hemolysis due to possible ABO incompatibility?
What is the recommended stepwise treatment for allergic rhinitis?
For an adult wanting to support normal gut function, prevent antibiotic‑associated diarrhea, or manage mild functional bowel symptoms (e.g., bloating, irregularity), what synbiotic capsule (probiotic plus prebiotic oligosaccharides) is recommended and are there any contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.